Edwards Lifesciences Corporation (EW)

E.W. Scripps, Crocs, and Latham Shares Skyrocket, What You Need To Know

ELF stock fell after e.l.f. Beauty’s Q4 earnings beat as investors weighed slower FY2027 growth, tariff pressure, rhode reliance and softer core brand momentum.

Recent share performance and business context Edgewise Therapeutics (EWTX) has drawn investor attention after a mixed stretch in the stock, with the price down about 9% over the past month but up roughly 4% over the past 3 months. Over longer periods, the stock shows a year to date gain of ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at consumer discretionary - broadcasting stocks, starting with E.W. Scripps (NASDAQ:SSP).

Edwards Lifesciences remains a key name in structural heart therapies. After its recent quarterly earnings release and updated 2025 guidance, investors are reassessing growth prospects, margins and regulatory risks around its heart-valve and critical-care portfolio.